Spero Therapeutics, Inc. (SPRO)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Sep 04, 16:00
1.21
0.00 (0.00%)
Pre-Market: 20:00
Spero Therapeutics SG&A Expense (TTM) : 19.85M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.85M |
| March 31, 2026 | 19.24M |
| December 31, 2025 | 21.18M |
| September 30, 2025 | 23.93M |
| June 30, 2025 | 24.96M |
| March 31, 2025 | 24.61M |
| December 31, 2024 | 23.70M |
| September 30, 2024 | 23.08M |
| June 30, 2024 | 23.59M |
| March 31, 2024 | 24.15M |
| December 31, 2023 | 25.55M |
| September 30, 2023 | 25.62M |
| June 30, 2023 | 26.54M |
| March 31, 2023 | 28.50M |
| December 31, 2022 | 36.48M |
| September 30, 2022 | 43.01M |
| June 30, 2022 | 47.53M |
| March 31, 2022 | 48.71M |
| Date | Value |
|---|---|
| December 31, 2021 | 41.70M |
| September 30, 2021 | 36.18M |
| June 30, 2021 | 30.34M |
| March 31, 2021 | 25.65M |
| December 31, 2020 | 21.44M |
| September 30, 2020 | 17.73M |
| June 30, 2020 | 16.55M |
| March 31, 2020 | 15.79M |
| December 31, 2019 | 15.59M |
| September 30, 2019 | 15.45M |
| June 30, 2019 | 14.45M |
| March 31, 2019 | 13.73M |
| December 31, 2018 | 12.89M |
| September 30, 2018 | 11.73M |
| June 30, 2018 | 12.25M |
| March 31, 2018 | 9.187M |
| December 31, 2017 | 6.143M |
| September 30, 2017 | 3.653M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 30.77M |
| Fortress Biotech, Inc. | 68.84M |
| Kura Oncology, Inc. | 135.28M |
| Legend Biotech Corp. | 376.01M |
| ACADIA Pharmaceuticals, Inc. | 620.29M |